Gilead says drug helped moderately ill coronavirus patients
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19.
Jun 1, 2020
0
2
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19.
Jun 1, 2020
0
2
For Ottawa scientist and neonatologist Dr. Bernard Thébaud, even a major paper that answers five significant questions still doesn't seem quite enough in his determined path to get his laboratory breakthrough into the neonatal ...
Dec 4, 2012
0
0
At least 504 terminally ill Californians have requested a prescription for life-ending drugs since a state law allowing physician-assisted deaths went into effect in June 2016, marking the first publicly released data on ...
Jun 1, 2017
0
0
Researchers from McMaster University have evaluated and determined the best ventilation strategy to prevent chronic lung disease, one of the most significant complications in preterm infants.
Aug 9, 2016
0
7
Matt Jackson was riding an electric bike through Bordeaux wine country when he started feeling strange. Nine days later, he's on a breathing machine in a French intensive care unit, unable to open his eyes, communicating ...
Sep 14, 2023
0
1